Clinical Trials Browser

Phase 2 × Terminated × Epirubicin × Clear all

NCT04770272 2026-01-12

neoMono

Phase 2 Terminated

442 enrolled 42 charts

Triple Negative Breast Neoplasms

NCT01779050 2022-11-01

Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells

Phase 2 Terminated

7 enrolled 8 charts

Breast Neoplasms

NCT01929811 2022-04-06

NeoMET

Phase 2 Terminated

pCR Rate

NCT03894007 2021-09-23

PREDIXIIHER2

Phase 2 Terminated

Breast Neoplasms

NCT01220128 2021-05-25

INDUCT

Phase 2 Terminated

66 enrolled 40 charts

Breast Neoplasms

NCT01690325 2018-08-13

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

Phase 2 Terminated

Breast Neoplasms

NCT01830270 2018-07-26

IPEC-GC

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms

NCT00176488 2017-03-23

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Phase 2 Terminated

31 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01123473 2016-10-12

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms

NCT00003852 2016-06-23

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

Phase 2 Terminated

GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

NCT01985841 2015-10-08

Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT01167738 2015-04-24

PACT-17

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT00756470 2014-11-17

Phase II Neoadjuvant in Inflammatory Breast Cancer

Phase 2 Terminated

15 enrolled 10 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00198172 2014-06-03

Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors

Phase 2 Terminated

Neoplasms, Germ Cell and Embryonal

NCT01301040 2013-08-30

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Phase 2 Terminated

Breast Neoplasms, Cardiotoxicity

NCT00431795 2013-02-13

Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00193024 2011-05-03

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00162812 2008-07-18

TOP

Phase 2 Terminated

Breast Neoplasms, Inflammatory Breast Neoplasms